1. The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review

   • Tiyi Morris
   • Fiona Aspinal
   • Manuel Gomes

   Systematic Review Open access 10 December 2022 Pages: 163 - 173

   

2. The Challenge for Orphan Drugs Remains: Three Case Studies Demonstrating the Impact of Changes to NICE Methods and Processes and Alternative Mechanisms to Value Orphan Products

   • Dawn Lee
   • Grant McCarthy
   • Fleur Chandler

   Original Research Article Open access 31 October 2022 Pages: 175 - 187

   

3. Estimating the Incidence-Based Cost of Illness Due to Hematopoietic Stem Cell Transplantation Using One-Year Insurance Claim Data in Korea

   • Sol Kwon
   • Hye-Young Kang

   Original Research Article Open access 28 September 2022 Pages: 189 - 197

   

4. A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada

   • Anuja Chatterjee
   • Gijs van de Wetering
   • Kavita Sail

   Original Research Article Open access 05 November 2022 Pages: 199 - 216

   

5. Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods

   • R. Brett McQueen
   • Nicholas D. Mendola
   • Zoltán Kaló

   Original Research Article Open access 01 November 2022 Pages: 217 - 228

   

6. Cost-effectiveness Analysis of Ocrelizumab for the Treatment of Relapsing and Primary Progressive Multiple Sclerosis in Portugal

   • Paulo Martins
   • Björn Vandewalle
   • Isabel Monteiro

   Original Research Article Open access 01 December 2022 Pages: 229 - 241

   

7. A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States

   • Rajiv Mallick
   • Rashad Carlton
   • Joris Van Stiphout

   Original Research Article Open access 09 February 2023 Pages: 243 - 255

   

8. Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in Ghana

   • Evans Otieku
   • Ama Pokuaa Fenny
   • Ulrika Enemark

   Original Research Article Open access 24 January 2023 Pages: 257 - 271

   

9. Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China

   • Shanlian Hu
   • Zhiliu Tang
   • Orban Holdgate

   Original Research Article Open access 10 March 2023 Pages: 273 - 284

   

10. Cost-Utility Analysis of the Caresyntax Platform to Identify Patients at Risk of Surgical Site Infection Undergoing Colorectal Surgery

    • Eoin Moloney
    • Atefeh Mashayekhi
    • Michael Branagan-Harris

    Original Research Article Open access 03 February 2023 Pages: 285 - 298

    

11. The Burden of Caring for Individuals with Tuberous Sclerosis Complex (TSC) Who Experience Epileptic Seizures: A Descriptive UK Survey

    • Hanna Skrobanski
    • Kishan Vyas
    • Siu Hing Lo

    Original Research Article Open access 09 February 2023 Pages: 299 - 312

    

12. A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America

    • Aaron Winn
    • Anirban Basu
    • Scott D. Ramsey

    Original Research Article Open access 11 February 2023 Pages: 313 - 320

    

13. The Cost-Effectiveness of a Dance and Yoga Intervention for Girls with Functional Abdominal Pain Disorders

    • Anna Philipson
    • Anna Duberg
    • Linda Ryen

    Original Research Article Open access 16 January 2023 Pages: 321 - 335